FDA Inspection 1032410 — Innovative Blood Resources, Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, Division Of New York Blood Center, Inc. on Oct 26, 2017 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 26, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln, NE (United States)